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CYTOTOXIC AGENT CONTAINMENT KIT
BACKGROUND OF THE INVENTION
This invention relates to apparatus for use in trans-
porting, storing, administering, and disposing of drugs
in a homesetting. Morespecifically, it relates to a prep-
aration and containmentkit for cytotoxic drugs.
There is a major trend in the health care industry
toward performing technical procedures outside major
hospitals, partly in order to reduce costs In addition, the
number of newly diagnosed cancer cases is increasing
each year. These two factors have resulted in shifting
significant amounts of cancer chemotheraphy from
major hospitals to homesettings, clinics, etc.
Theincreasing use ofhome chemotherapy has a num-
ber of benefits, but it also has somerisks. One risk stems
from the highly toxic nature ofcommonly used antineo-
plastic drugs. In a hospital setting, these drugs are
stored, prepared, and administered very carefully by
trained professionals-so as to minimize therisk of acci-
dental exposure of those who handle the drugs and the
apparatus used to prepare and administer them. In a
hospital, safety equipment such as biosafety cabinets,
individual refrigeration units, hazardous waste disposal
facilities, and dedicated work areas help minimize the
risk of accidental exposure. However, in a homesetting,
much. of this safety equipment will not be available.
Accordingly, unless appropriate measures are taken,
home chemotherapy patients, nurses aiding in their
treatment, and family members will be at risk of acci-
dental exposure to cytotoxic agents.
Accordingly, a very important need exists for appara-
tus that will facilitate the safe storage, preparation, use,
and disposal of cytotoxic drugs and related equipment
such as needles in a homesetting.
SUMMARYOF THE INVENTION
Thepresent inventionrelates to a disposable contain-
ment kit for drugs and related equipment. Thekit in-
cludes a bottom enclosure member, and a top enclosure
memberwhichis hingedly connected at one edge to the
bottom enclosure member, whereby the top enclosure
and bottom enclosure membercan be closed to define a
sealed enclosure. The kit also includes a sealable, sub-
stantially leakproof, nonpermeable drug container
whichis adapted to hold drugs and apparatus needed to
administer the drugs, and a similar sealable, nonpermea-
ble waste container which is adapted to hold used drug
containers and apparatus. In addition, the kit includes at
least one storage compartment which is located in the
bottom enclosure member, and a removable tray which
is adapted to rest on top of the storage compartment.
The tray can provide an aseptic, horizontal. work sur-
face on whichto prepare drugs for administration. This
kit can be provided with a handle for carrying. In addi-
tion,it will usually include at least-one absorbent pad on
the removable tray, so that any materials which are
spilled can be absorbed, thereby minimizing the risk of
human contact with the toxic agents.
The entire kit is a lightweight, partially-disposable
unit similar in size to a small brief case. The required
drugs would typically be in bags or bottles which are
located in the drug container. Protective gloves, hypo-
dermic needles, intravenous connecting tubes, infusion







either in the drug container or in a storage compart-
ment.
Whenthe patient is ready to use the kit, he can un-
latch the kit, and remove the drugs and apparatus
needed to administer them. The removable tray pro-
vides a clean, dedicated work surface on which to pre-
pare the drugs and apparatus. After the drugs have been
administered, empty drug containers, used needles, and
other contaminated apparatus can be placed in the
waste container, which is then sealed. The entire kit is
then closed, and can be delivered to an appropriate
hospital or waste disposal facility.
The kit of the present invention can be designed ei-
ther for a’single use or for multiple uses. In either event,
the contents of the kit along with the tray and contain-
ers are disposed of when the patient is done withit.
One specific embodiment of the present invention
includes a rectangular, nonpermeable bottom enclosure
member which has a rectangular base and four rectan-
gular side walls, the base being divided into a first zone
and a second zone, with the two zones being divided by
a vertical wall. This embodimentalso includes a rectan-
gular, nonpermeable top enclosure member which has a
rectangularlid and four rectangular side walls, one edge
of one side wall being hingedly connected to a corre-
sponding side wall of the bottom enclosure member.
The kit also has a releasable latch to hold the bottom
enclosure member and top enclosure member together
in a closed position. A sealable, nonpermeable drug
container in the form of a rectangular box with an open
top is also included. This container rests in the first zone
of the bottom enclosure member, and also has a latch-
able toplid and a latch to secure the toplid in the closed
position. This container could be insulated for drugs
that require cold storage during transportation. Like-
wise, there is a sealable, nonpermeable waste container
whichis also in the form of a rectangular box with an
open top, this container also resting in the first zone of
the bottom enclosure member and having a latchable
top lid with a latch to secure the top lid in the closed
position. A plurality of storage compartments are lo-
cated in the second zoneof the bottom enclosure mem-
ber, these storage compartments being defined by side
walls of the bottom enclosure memberandat least one
internal vertical wall, the storage compartments further
being open at their tops. Finally, a removable horizontal
tray rests on top of the storage compartments and cov-
ers the second zone of the bottom enclosure member.
The present invention has a number of benefits. It
facilitates the use of parenteral drugs, especially cyto-
toxic agents, outside of major treatment facilities. It
provides a convenient, clean, portable work area for the
preparation of chemotherapy and a safe means ofstor-
age and disposal of drugs and waste material resulting
from their use. The present invention reduces the possi-
bility of inadvertent exposure to hazardous cytotoxic
agents by patients’ families and health care personnel. It
also provides a safe method for disposal of needles
which will reduce inadvertent needle sticks.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is.a perspective view of a cytotoxic agent
containment kit in accordance with the present inven-
tion.
FIGS.2A,2B, and 2C are top, front, and side views,
respectively, of the kit in an open position.
FIG.3 is a top view of the kit in the open position
with the tray removed.
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FIG.4 is a perspective view of a drug container with
its top removed.
FIG.5 is a perspective view of a removable tray.
DETAILED DESCRIPTION OF A SPECIFIC
EMBODIMENT
A cytotoxic agent containment kit 10 is similar in
shape to a brief case. The kit 10 includes a bottom enclo-
sure member 12 and a top enclosure member 14. The
two enclosure members 12 and 14 are connected by a
hinge 16 running along one edgeofeach enclosure. One
or more outer latches 18 can be provided to secure the
bottom enclosure member and top enclosure member
together whenthe kit is in the closed position. (FIG. 1
shows a version having one latch, while FIGS. 2A-C
and 3 show a version with two latches.) Whenthekit is
closed, it provides a tight seal to prevent leakage of any
spilled drugs.
Whenthekit is open as shownin FIG.1, one sees the
top of a drug container 20, a waste container 22, and a
removable tray 24. A narrow divider wall 26 runs from
one side of the bottom enclosure member 12 to the
other, thereby separating the removable tray 24 from
the drug container 20 and waste container 22. A corre-
sponding divider wall 28 is located in the top enclosure
member 14. When thekit is closed, the divider wall 26
in the bottom enclosure member12 and the divider wall
28 in the top enclosure member 14 are aligned one on
top of the other.
Both the bottom enclosure member 12 and the top
enclosure member14are rectangular in shape, although
they can have rounded corners and edges. The former
has a rectangular bottom 30 and four side walls 32. The
top enclosure member14 likewise has a rectangular lid
34 and four rectangular side walls 36. A handle 38 is
provided on oneside wall 32 of the bottom enclosure 12
for ease of carrying. ;
As can be seen in FIGS.1, 2B and 2C,the drug con-
tainer 20, waste container 22, and the upper edgesofthe
removable tray 24 extend slightly above the top of the
bottom enclosure member 12. When the upper enclo-
sure member 14 is swung downinto the closed position,
the flat lid 34 of the top enclosure member 14 should be
in very close proximity to the upper edges of the remov-
able tray 24, and the drug and waste containers 20 and
22. This will prevent the two containers 20 and 22 and
the tray 24 from shifting while the kit is being trans-
ported, by allowing no room for those items to move
within the enclosure.
The divider wall 26 in the bottom enclosure member
12 divides it into two zones. The first zone comprises
the spaces for receiving the drug container 20 and the
waste container 22. The second zone comprises the
space in which the removable tray 24 rests. The first
zoneis fully filled by the drug container 20 and waste
container 22, and therefore they cannot shift back and
forth when the kit is transported. Likewise, the entire
area of the second zone is covered by the removable
tray 24 so thatit too will not shift during transportation.
Turning now to FIG.3, when the removable tray 24
is removed, a plurality of storage compartments 40 can
be seen. These storage compartments 40 are defined by
someofthe side walls 32 of the bottom enclosure mem-
ber 12, along with a plurality of internal divider walls
42. If desired, another divider wall 44 can be used to
separate the space for the drug container 20 from that














The drug container 20, which is shown as beingre-
moved in FIG. 3, can be seen in more detail in FIG.4.
It includes a box having a flat bottom and four side
walls 46 and a removable top lid 48. The inner surface
of the bottom and side walls can be thermally insulated
if desired. A latch 50 is used to hold the lid 48 in place
whenthelid is in the closed position, and to release the
lid when access is needed to the contents of the con-
tainer 20. The latch 50 is preferably located in a small
recess 52.
The waste container 22 would have the same con-
struction. Preferably within the waste container 22 is a
specific area to accommodate used needles. This area
will protect the user from accidental used needlesticks
by isolating the used needles from further touch. This
can be accomplished either by a one-way entrapment
door or by a dartboard type material into which the
needle is stuck upon disposal.
Although FIG. 4 shows the lid 48 as being com-
pletely removable from the container 20, it would also
be possible for the lid and container to be hingedly
connected at one edge.
The removable tray 24 is shown in more detail in
FIG.5. Thetray 24 has a flat bottom and fourside walls
54. If desired, small apertures 56 can be made in oppos-
ing side walls 54 so as to provide hand holds for moving
the tray 24. Inside the tray 24, it is preferred to have a
plurality of absorbent pads 58 to soak up any liquids that
are spilled. One example of a suitable pad material is the
Chemo Safety Prep mat available from Chemo Safety
Systems, San Diego, Calif. The pads §8 are preferably
removable, and located one on top of another, so that a
contaminated pad can be removed and placed in the
waste container 22, leaving a clean pad remaining on
the tray 24. It is also possible to treat the pad with a
chemical reagent that will change color when con-
tacted by a preselected cytotoxic agent. This will pro-
vide the user with a warning when a quantity of the
cytotoxic agent has been spilled on the pad, so that the
user will know of the need to avoid that spill and to
dispose of the absorbent pad 58.
In another embodiment, clean pads could be stored in
a storage compartment 40, and removedas needed to be
placed on the tray 24.
Although the tray is shown in the drawings as not
covering the drug container 20 or the waste container
22, another embodimentof the invention could have a
tray that covered them as well.
Thekit 10 would normally be provided to a patient
with a supply of the required chemotherapy drugs in
appropriate bagsor bottles, infusion pumps, etc. placed
in the drug container 20. The kit would likely also con-
tain apparatus such as infusion pumps, hypodermic
needles, tubing, protective gloves, and other things that
would be needed to prepare and administer the drugs.
These items could be placed in the drug container 20,or
in any of the storage compartments 40. Whenthe pa-
tient or nurse is ready to administer the drugs, the drugs
and other apparatus are withdrawn from the drug con-
tainer 20 and the storage compartments 40, and are
placed on top of the tray 24. With the tray 24 removed
from the top of the storage compartments 490,it pro-
vides an aseptic work surface for the necessary opera-
tions to prepare the drugs for administration.
After administration of the drugs is complete, empty
drug bags or bottles, used needles, used gloves, and
other contaminated materials can be placed in the waste
container 22, and oncethe toplid of the waste container
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is in place, the contaminated materials are then effec-
tively sealed. within a leakproof, nonpermeable con-
tainer, thereby minimizing the risk of exposure to the
contents thereof. The waste container 22 preferably
includes a repository for used needles. 5
It is possible to design a kit in accordance with the
present invention for multiple uses, or for a single use.
In either case, once the desired numberofuses are com-
plete, the tray and containers can be disposed of in an
appropriate waste disposal facility. The outer case is 10
preferably constructed of a more durable plastic and
may be cleaned and reused. This eliminates the need to
dispose of the individual items separately, and thereby
significantly reduces the required handling and associ- _
ated risk of inadvertent exposure to cytotoxic agents. 15
The tray and containers of a kit in accordance with
the present invention are preferably constructed of a
light, durable material, whichis inexpensive enough to
make it practical to discard them. Further,it is pre-
ferred that the entire kit be capable of being placed in a 20
refrigerator. A variety of plastics would be satisfactory
for this purpose.
Although the present invention has been describedin
terms of chemotherapy drugs,it could also be used with
antibiotics, nutritional supplements, or the like. When it 25
is used with cytotoxic agents, it will usually have a label
on its exterior and on the drug and waste containers to
identify them as containing hazardous material.
The preceding description is intended to illustrate
one embodiment of the present invention. It is not in- 30
tended to be an exhaustive description of all possible
embodiments of the present invention. Those skilled in
this field will recognize that a number of modifications
could be made to this embodiment which would still
remain within the scope of the present invention. 35
Weclaim:
1. A disposable containment kit for drugs, including:
a bottom enclosure member;
a top enclosure member whichis hingedly connected
at one edge to the bottom enclosure, whereby the 40
top enclosure and bottom enclosure can be closed
to define a sealed enclosure;
a sealable, substantially leakproof drug container
which is impermeableto liquid and located within
the enclosure defined by the top enclosure member 45
and the bottom enclosure memberandis capable of
holding drugs and apparatus needed to administer
the drugs;
a sealable waste container which is impermeable to
liquid and located within the enclosure defined by 50
the top enclosure member and the bottom enclo-
sure member and is capable of holding used drug
containers and apparatus;
at least one storage compartment whichis located in
the bottom enclosure; 55
a removable tray which is adapted to rest on top of
the storage compartment, and which can be re-
moved to provide an aseptic work surface on
which to prepare drugs for administration; and
at least one absorbent pad on the removable tray; 60
which absorbent pad covers the upper surface of the
tray and is removable from the tray, and which
absorbent pad contains a chemical reagent which
changes in color when a selected drug contacts it.
2. A cytotoxic agent containmentkit, including: 65
a rectangular bottom enclosure member which is
impermeable to liquid and has spaces for a drug
container and a waste container, and at least one
6
storage compartment which is located beside the
drug container and waste container;
a rectangular top enclosure member which is imper-
meable to liquid and hingedly connected at one
edge to the bottom enclosure, whereby the top
enclosure and bottom enclosure can be closed. to
define a sealed enclosure;
a releasable latch to hold the bottom enclosure and
top enclosure in a mutually sealed position;
a sealable drug container which is impermeable to
liquid and comprises a rectangular box with an
open top, a top lid which can be closed to seal the
container, and a latch to secure the top lid in the
closed position;
a sealable waste container which is impermeable to
liquid and comprises a rectangular box with an
opentop, a top lid which can be closed to seal the
container, and a latch to secure the top lid in the
closed position;
at least one storage compartment whichis located in
the bottom enclosure;
a rectangular, removable, horizontal tray which is
adapted to rest on top of the storage compartment
in the bottom enclosure, and provides an aseptic,
horizontal work surface.on which to prepare drugs
for administration; and
at least one absorbent pad on the removable tray
which absorbent pad covers the upper surface of the
tray and is removable from the tray, and which
absorbent pad contains a chemical reagent which
changes in color when a selected drug contacts it.
3. A cytotoxic agent containment kit, including:
a rectangular, nonpermeable bottom enclosure mem-
ber which has a rectangular base and four rectan-
gular side walls, the base being dividedinto a first
zone and a second zone, with the two zones being
divided by a vertical wall;
a rectangular, nonpermeable top enclosure member
which has a rectangular lid and four rectangular
side walls, one edge ofoneside wall being hingedly
connected to a corresponding side wall of the bot-
tom enclosure;
a releasable latch to hold the bottom enclosure and
top enclosure together in a closed position;
a sealable, nonpermeable drug container in the form
of a rectangular box with an open top, the con-
tainer resting in the first zone of the bottom enclo-
sure, the container further having a latchable top
lid and a latch to secure the top lid in the closed
position;
a sealable, nonpermeable waste container in the form
of a rectangular box with an open top, the con-
tainer resting in the first zone of the bottom enclo-
sure, the container further having a latchable top
lid and a latch to secure the top lid in the closed
position, and the container including a repository
for used needles;
a plurality of storage compartments in the second
zone of the bottom enclosure, the storage compart-
ments being defined by side walls of the bottom
enclosure and at least oneinternal vertical wall, the
storage compartments being open at their tops; and
a removable, horizontal tray whichrests on top of the
storage compartments and covers the second zone
of the bottom enclosure, and which provides an
aseptic, horizontal work surface on which to pre-
pare drugs for administration.
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4. The kit of claim 3, further including a handle for 7. The kit of claim 6, where the absorbent pads are
carrying the kit. individually removable from the tray.
5. The kit of claim 3, where the drug containeris 8. The kit of claim 6, where each absorbent pad con-
thermally insulated. tains a chemical reagent which changes in color when a
6. The kit of claim 3, further comprising a plurality of 5 selected drug contactsit.
*absorbent pads on the removable tray. * ** *
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